Clinical Trial Update: Arginine as an Adjuvant Treatment Against Tuberculosis [NA]

View source ↗

Summary

This entry notes the completed status of a clinical trial evaluating arginine as an adjunct treatment for tuberculosis, including participants with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Linkoeping University | Conditions: Tuberculosis, HIV | NA | Status: COMPLETED